SE407333B - Forfarande for rening av gamma-globulin, serskilt antilymfocyt-gamma-globulin - Google Patents
Forfarande for rening av gamma-globulin, serskilt antilymfocyt-gamma-globulinInfo
- Publication number
- SE407333B SE407333B SE7209600A SE960072A SE407333B SE 407333 B SE407333 B SE 407333B SE 7209600 A SE7209600 A SE 7209600A SE 960072 A SE960072 A SE 960072A SE 407333 B SE407333 B SE 407333B
- Authority
- SE
- Sweden
- Prior art keywords
- globulin
- stroma
- erythrocyte
- solution
- acrinol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 238000000746 purification Methods 0.000 title claims description 3
- 108010074605 gamma-Globulins Proteins 0.000 title description 41
- 210000003743 erythrocyte Anatomy 0.000 claims description 27
- 230000000890 antigenic effect Effects 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 21
- 108010017384 Blood Proteins Proteins 0.000 claims description 20
- 102000004506 Blood Proteins Human genes 0.000 claims description 20
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 claims description 19
- 210000004698 lymphocyte Anatomy 0.000 claims description 19
- 230000009102 absorption Effects 0.000 claims description 14
- 238000010521 absorption reaction Methods 0.000 claims description 14
- 238000005119 centrifugation Methods 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 241000894007 species Species 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 102000001554 Hemoglobins Human genes 0.000 claims description 3
- 108010054147 Hemoglobins Proteins 0.000 claims description 3
- 239000012503 blood component Substances 0.000 claims description 3
- 230000003053 immunization Effects 0.000 claims description 2
- 238000002649 immunization Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 235000004252 protein component Nutrition 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 102000006395 Globulins Human genes 0.000 claims 4
- 108010044091 Globulins Proteins 0.000 claims 4
- 239000012153 distilled water Substances 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 description 20
- 239000000243 solution Substances 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 210000002966 serum Anatomy 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 241000283073 Equus caballus Species 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000027758 ovulation cycle Effects 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000282579 Pan Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- QWAGALBSTFENEE-UHFFFAOYSA-N 4-aminoacridine Chemical compound C1=CC=C2N=C3C(N)=CC=CC3=CC2=C1 QWAGALBSTFENEE-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000002572 Alpha-Globulins Human genes 0.000 description 1
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 239000009261 D 400 Substances 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000001251 acridines Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 230000000781 anti-lymphocytic effect Effects 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- -1 halogen salts Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 229910052749 magnesium Chemical class 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/837—Lymph; lymph-glands; thymus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/838—Marrow; spleen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16569771A | 1971-07-23 | 1971-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE407333B true SE407333B (sv) | 1979-03-26 |
Family
ID=22600062
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7209600A SE407333B (sv) | 1971-07-23 | 1972-07-21 | Forfarande for rening av gamma-globulin, serskilt antilymfocyt-gamma-globulin |
| SE7809384A SE447339B (sv) | 1971-07-23 | 1978-09-06 | Forfarande for separation av erytrocytstroma |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7809384A SE447339B (sv) | 1971-07-23 | 1978-09-06 | Forfarande for separation av erytrocytstroma |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3745155A (OSRAM) |
| JP (1) | JPS5732044B1 (OSRAM) |
| AR (1) | AR192808A1 (OSRAM) |
| AU (1) | AU461489B2 (OSRAM) |
| BE (1) | BE786564A (OSRAM) |
| CA (1) | CA971880A (OSRAM) |
| CH (1) | CH584126A5 (OSRAM) |
| DE (1) | DE2235600C3 (OSRAM) |
| DK (1) | DK132689C (OSRAM) |
| FR (1) | FR2147100B1 (OSRAM) |
| GB (2) | GB1377101A (OSRAM) |
| IL (1) | IL39911A (OSRAM) |
| NL (1) | NL173918C (OSRAM) |
| SE (2) | SE407333B (OSRAM) |
| ZA (1) | ZA724738B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2222084B1 (OSRAM) * | 1973-03-22 | 1976-05-14 | Fontaine Michel | |
| NL7602422A (nl) * | 1976-03-08 | 1977-09-12 | Leuven Res & Dev Vzw | Trombosetest. |
| IT1143768B (it) * | 1977-10-31 | 1986-10-22 | Boehringer Biochemia Srl | Procedimento per la produzione di un anticorpo anti-hcg,particolarmente utile per la diagnosi della gravidanza |
| US4731336A (en) * | 1982-06-14 | 1988-03-15 | Amersham International Plc | Immunoassay for complement fragments |
| US5219578A (en) * | 1991-02-25 | 1993-06-15 | Innovet, Inc. | Composition and method for immunostimulation in mammals |
| GB201520903D0 (en) | 2015-11-26 | 2016-01-13 | Qbd Qs Ip Ltd | Purification method |
-
0
- BE BE786564D patent/BE786564A/xx not_active IP Right Cessation
-
1971
- 1971-07-23 US US00165697A patent/US3745155A/en not_active Expired - Lifetime
-
1972
- 1972-07-04 AR AR242887A patent/AR192808A1/es active
- 1972-07-10 CA CA146,736A patent/CA971880A/en not_active Expired
- 1972-07-11 GB GB3241672A patent/GB1377101A/en not_active Expired
- 1972-07-11 ZA ZA724738A patent/ZA724738B/xx unknown
- 1972-07-11 GB GB2429574A patent/GB1377102A/en not_active Expired
- 1972-07-13 CH CH1054272A patent/CH584126A5/xx not_active IP Right Cessation
- 1972-07-14 AU AU44582/72A patent/AU461489B2/en not_active Expired
- 1972-07-14 IL IL39911A patent/IL39911A/xx unknown
- 1972-07-19 NL NLAANVRAGE7209952,A patent/NL173918C/xx not_active IP Right Cessation
- 1972-07-20 DE DE2235600A patent/DE2235600C3/de not_active Expired
- 1972-07-21 DK DK363972A patent/DK132689C/da active
- 1972-07-21 FR FR7226377A patent/FR2147100B1/fr not_active Expired
- 1972-07-21 SE SE7209600A patent/SE407333B/sv unknown
- 1972-07-24 JP JP7351172A patent/JPS5732044B1/ja active Pending
-
1978
- 1978-09-06 SE SE7809384A patent/SE447339B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE447339B (sv) | 1986-11-10 |
| BE786564A (fr) | 1973-01-22 |
| DE2235600C3 (de) | 1981-07-30 |
| CH584126A5 (OSRAM) | 1977-01-31 |
| NL7209952A (OSRAM) | 1973-01-25 |
| DK132689B (da) | 1976-01-26 |
| FR2147100A1 (OSRAM) | 1973-03-09 |
| NL173918B (nl) | 1983-11-01 |
| DK132689C (da) | 1976-07-26 |
| JPS5732044B1 (OSRAM) | 1982-07-08 |
| DE2235600A1 (de) | 1973-02-01 |
| US3745155A (en) | 1973-07-10 |
| AR192808A1 (es) | 1973-03-14 |
| ZA724738B (en) | 1973-03-28 |
| GB1377102A (en) | 1974-12-11 |
| DE2235600B2 (de) | 1980-10-02 |
| FR2147100B1 (OSRAM) | 1976-08-06 |
| SE7809384L (sv) | 1978-09-06 |
| IL39911A0 (en) | 1972-09-28 |
| NL173918C (nl) | 1984-04-02 |
| IL39911A (en) | 1975-04-25 |
| CA971880A (en) | 1975-07-29 |
| AU461489B2 (en) | 1975-05-29 |
| AU4458272A (en) | 1974-01-17 |
| GB1377101A (en) | 1974-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schrohenloher et al. | Activity of dissociated and reassociated 19S anti-γ-globulins | |
| Alter et al. | Further studies on a" new" human isoprecipitin system (Australia antigen) | |
| US4357272A (en) | Recovering purified antibodies from egg yolk | |
| Jorpes | The protein component of the erythrocyte membrane or stroma | |
| Frommhagen et al. | The role of aggregated γ-globulins in the anticomplementary activity of human and animal sera | |
| Stern et al. | Electrophoresis in medicine | |
| NO753638L (OSRAM) | ||
| JP2009521520A (ja) | 抗Ａおよび抗Ｂ抗体、ならびに多反応性ＩｇＧが減少した免疫グロブリンＧ（ＩｇＧ）濃縮物 | |
| TWI226834B (en) | Process for selectively isolating antibody isomers | |
| Gerin et al. | Biophysical Characterization of the adr Subtype of Hepatitis B Antigen and Preparation of Anti-γ Sera in Rabbits | |
| JPH0354120B2 (OSRAM) | ||
| Shedlovsky et al. | THE LS-ANTIGEN OF VACCINIA: II. Isolation of a Single Substance Containing Both L-and S-Activity | |
| US2793203A (en) | Process of preparing stable, highly purified gamma globulin preparations | |
| SE407333B (sv) | Forfarande for rening av gamma-globulin, serskilt antilymfocyt-gamma-globulin | |
| Lennette et al. | Studies on epidemic influenza virus: The nature and properties of the complement-fixing antigen | |
| US3903254A (en) | Separation of erythrocyte stroma from lysing medium and hemoglobin with acrinol | |
| Zanetti et al. | Passive Heymann's nephritis as a model of immune glomerulonephritis mediated by antibodies to immunoglobulins | |
| EP0068465B1 (en) | Non-a, non-b hepatitis-associated antibody conjugate, the use thereof and detection reagent | |
| US3607857A (en) | Process of removing acrinol from gamma globulin using siliceous material such as silica gel | |
| Washburn et al. | Chronic arthritis of rabbits induced by mycoplasmas II. antibody response and the deposition of immune complexes | |
| US20090181043A1 (en) | Method for Producing Human Anti-Thymocyte Immunoglobulins | |
| US4197238A (en) | Method of preparation of human albumin using polyethylene glycol | |
| Spooner et al. | The isolation of ox red cell membrane antigens: antigens associated with sialoprotein | |
| Hansson et al. | Some factors affecting precipitation and complex formation of an IgG cryoglobulin | |
| Ruckerbauer et al. | Hog Cholera: I. Investigation of the Agar Double-Diffusion Precipitation Test for The Detection of the Virus in Swine Tissue |